Background: Based on the results of a recent randomized controlled trial, carotid artery stenting (CAS) was regarded as a relatively safe, less invasive treatment of internal carotid artery stenosis. However, cerebral thromboembolic events are the most common complications of CAS. Especially acute stent thrombosis following CAS will be fatal without prompt diagnosis and revascularization. Case Report: We report a case of acute stent thrombosis in whom carotid revascularization was performed successfully via arterial thrombolysis and balloon postdilation. A 79-year-old man with hypertension was hospitalized for an episode of transient ischemic attack. Computed tomography angiography revealed subtotal occlusion in the left carotid artery. Aspirin (100 mg) and clopidogrel (75 mg) were administered daily for 5 days before the procedure. CAS was performed under local anesthesia. The first postprocedural angiogram showed the stent looked good. However, a repeat angiogram showed in-stent thrombosis 2 min after withdrawal of the cerebral protection filter. Interestingly, the patient presented no neurologic deficit. After an additional 2,000 U of heparin had been administered intravenously, a microcatheter (SL-14; Boston Scientific, USA) was positioned to the in-stent thrombosis. Next, a total dose of 10 mg of recombinant tissue plasminogen activator was injected into the thrombus via the microcatheter within 10 min, which led to partial recanalization with antegrade flow. However, complete occlusion of the lesion occurred 5 min later. Under the guidance of angiography roadmap, a protection filter (Emboshield NAV6; Abbott Vascular, USA) was deployed at the distal part of the stent and redilation of the stent was per- formed with a 5 × 30 mm balloon (Viatrac 14 Plus; Abbott Vascular) at 14 atm. Finally, carotid revascularization was performed successfully, proven by postprocedural angiogram. Conclusion: Acute carotid stent thrombosis (ACST) can have devastating effects on the survival of the patient. For ACST when the stent does not fully adhere to the blood vessel, a mechanical approach should be a feasible solution to the problem.
Introduction
Based on the results of a recent randomized controlled trial, carotid artery stenting (CAS) was regarded as a relatively safe, less invasive treatment of internal carotid artery stenosis [1] . Similar to other treatments for internal carotid artery stenosis, cerebral thromboembolic events are the most common complications of CAS. Especially acute stent thrombosis following CAS will be fatal without prompt diagnosis and revascularization.
Here, we reported a case of acute stent thrombosis in whom carotid revascularization was performed successfully via arterial thrombolysis and balloon postdilation. The related publications were reviewed to assess the feasibility of vascular recanalization.
Case Report
A 79-year-old man with hypertension was hospitalized for an episode of transient ischemic attack, which was etiologically attributed to severe left internal carotid artery stenosis. Two months before, he had been admitted to a local hospital with transient right-sided hemiparesis. Aspirin (100 mg), together with atorvastatin (20 mg), were orally administered daily. On the onset of the event, a left cerebral hemisphere infarct was shown by brain magnetic resonance imaging. Computed tomography angiography revealed subtotal occlusion of the left carotid artery (Fig. 1 ) and approximately 60% stenosis in the contralateral carotid bifurcation. In 2007, the patient was fully recovered from the first-line treatment, and informed consent was obtained from the patient.
Aspirin (100 mg) and clopidogrel (75 mg) were administered daily 5 days before the procedure. CAS was performed under local anesthesia. Intraoperatively, heparin was administered intravenously at a dose of 5,000 U (100 U/kg) bolus immediately after femoral artery puncture and at a dose of 1,000 U/h during the procedure. Angiography revealed almost complete left carotid artery occlusion (Fig. 2a) . After a cerebral protection filter (spider FX; EV-3, USA) had been positioned, the stenosis of the left internal carotid artery was predilated with a 3 × 20 mm balloon (Savvy; Cordis, The Netherlands) and a 4 × 30 mm balloon (Viatrac 14 Plus; Abbott Vascular, USA). An 8 × 30 mm self-expandable carotid stent (Xact; Abbott Vascular) was then implanted and released using a 0.014-inch guidewire and a 6-F guide catheter. The first postprocedural angiogram showed the carotid stent was not well and dilated by a 5 × 20 mm balloon at 10 atm (Fig. 2b) . However, a repeat angiogram showed in-stent thrombosis 2 min after withdrawal of the cerebral protection filter (Fig. 3) . Interestingly, the patient presented no neurologic deficit. After an additional 2,000 U of heparin had been administered intravenously, a microcatheter (SL-14; Boston Scientific, USA) was positioned to the in-stent thrombosis. Next, a total dose of 10 mg of recombinant tissue plasminogen activator was injected into the thrombus via the microcatheter within 10 min, which led to partial recanalization with antegrade flow (Fig. 4) . However, complete occlusion of the lesion occurred 5 min after carotid thrombolysis according to the repeat angiogram (Fig. 5) . Under the guidance of angiography roadmap, a protection filter (Emboshield NAV6; Abbott Vascular) was deployed at the distal part of the stent, and redilation of the stent was performed with a 5 × 30 mm balloon (Viatrac 14 Plus) at 14 atm. Finally, carotid revascularization was performed successfully, proven by postprocedural angiogram (Fig. 6a, b) .
A thromboelastography test showed that the patient with the gene CYP2C19 had a normal response to clopidogrel. Clopidogrel (75 mg) and atorvastatin (20 mg) were administered daily. At the 10-month followup period, the patient showed no signs of neurologic deficits, without any evidence of restenosis or occlusion after CAS proven by duplex ultrasonography (Fig. 7) .
Discussion and Literature Review
Acute carotid stent thrombosis (ACST) is a very rare complication of CAS and can have devastating effects on patient survival. The probable factors contributing to ACST include systemic inadequate antiplatelet treatment, clopidogrel hyporesponse, local vessel dissection, a hypercoagulable state, severe plaque protrusion, vasospasm, intimal injury, stent thrombogenicity, early stent restenosis, and stent underexpansion [2] . In our case, the patient without coagulation abnormality was administered aspirin and clopidogrel daily before the CAS; he showed no clopidogrel resistance. Thus, the probable cause of ACST was that the carotid stent failed to completely stick to the lining of the blood vessel, which led to excessive residual stenosis. Vascular endothelial injury may be another probable reason. Early and rapid diagnosis and treatment of ACST was crucial for the improvement of the patient's outcome. During the CAS procedure, we adopted a "wait-and-see" strategy. i.e., observation of vascular appearances for a few minutes after carotid stent deployment. When carotid artery occlusion occurred during the wait-and-see period, the probable cause was immediately identified by selective angiography without retrieval of the guiding catheter or sheath. The proper treatment method was selected timely according to the angiogram results. Thus, it is probably a feasible method to ensure early and rapid diagnosis of ACST.
In papers published after 2000, in which some effective treatment strategies were listed, only 19 cases of ACST were reported [3] [4] [5] . The proper methods depended largely on the neurologists' experience, thrombotic state, and the intervention materials available. Though both mechanical thrombectomy and cerebral endarterectomy were effective therapies for ACST [3] , it may be not the case for this patient due to more serious complications triggered by possible overuse of antiplatelet medication.
The forced arterial suction thrombectomy technique using the Penumbra System reperfusion catheter was an alternative approach for the management of ACST [3] [4] [5] and was mainly used for recanalization of acute occlusion of the major cerebral artery. However, it remains unclear whether it can resolve thrombi caused by plaque protrusion.
Another strategy mentioned in the treatment of ACST included systemic or local administration of a glycoprotein IIb-IIIa inhibitor or recombinant tissue plasminogen activator [3] [4] [5] . However, when the thrombus was not completely dissolved, the mechanical technique (i.e., percutaneous angioplasty or stent-in-stent) was superior to thrombolytic agents for the treatment of ACST. In our case, ACST was attributed to poor stent adherence. Artery thrombolysis partly dissolved the in-stent thrombosis temporally, and balloon redilation was capable of opening circumferentially to displace the thrombus, restoring the blood flow in the occluded vessel. Thus, the stent adhered completely to the lining of the blood vessel. Once antegrade flow was restored, endogenous thrombolysis could dissolve the thrombus.
In conclusion, ACST is a very rare complication of CAS and can have devastating effects on the survival of the patient. For ACST when the stent does not fully adhere to the blood vessel, a mechanical approach should be a feasible solution to the problem.
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